NIOX Group Plc (AIM:NIOX)

Market Cap	252.32M
Revenue (ttm)	39.00M
Net Income (ttm)	11.70M
Shares Out	397.98M
EPS (ttm)	0.03
PE Ratio	26.01
Forward PE	24.85
Dividend	0.01 (1.63%)
Ex-Dividend Date	May 23, 2024

Volume	2,309,087
Average Volume	636,752
Open	62.60
Previous Close	61.40
Day's Range	61.33 - 63.80
52-Week Range	57.00 - 80.00
Beta	1.00
RSI	61.11
Earnings Date	Apr 1, 2025

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group ...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2006
• Employees: 92
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2023, NIOX Group's revenue was 36.80 million, an increase of 17.57% compared to the previous year's 31.30 million. Earnings were 10.70 million, a decrease of -33.54%.